Aisling Capital Management as of Dec. 31, 2020
Portfolio Holdings for Aisling Capital Management
Aisling Capital Management holds 16 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Bridgebio Pharma (BBIO) | 48.4 | $284M | 4.0M | 71.11 | |
| Eidos Therapeutics | 25.2 | $148M | 1.1M | 131.58 | |
| Harmony Biosciences Hldgs In (HRMY) | 5.2 | $31M | 843k | 36.15 | |
| Spruce Biosciences (SPRB) | 5.0 | $29M | 1.2M | 24.31 | |
| Syndax Pharmaceuticals (SNDX) | 3.9 | $23M | 1.0M | 22.24 | |
| Avrobio Ord (AVRO) | 2.4 | $14M | 1.0M | 13.94 | |
| Aeglea Biotherapeutics | 2.3 | $13M | 1.7M | 7.87 | |
| Poseida Therapeutics I (PSTX) | 2.0 | $11M | 1.0M | 10.97 | |
| Verona Pharma Plc ads (VRNA) | 1.6 | $9.3M | 1.3M | 7.00 | |
| Atreca Cl A Com (BCEL) | 1.1 | $6.3M | 388k | 16.15 | |
| Nabriva Therapeutics SHS | 0.8 | $4.6M | 1.9M | 2.42 | |
| Aclaris Therapeutics (ACRS) | 0.7 | $4.1M | 635k | 6.47 | |
| Marker Therapeutics Ord | 0.5 | $2.9M | 2.0M | 1.45 | |
| Obseva Sa | 0.5 | $2.9M | 1.4M | 2.08 | |
| Sunesis Pharmaceuticals Inc Ne | 0.3 | $2.0M | 1.0M | 1.99 | |
| Zosano Pharma Corp | 0.2 | $1.4M | 2.7M | 0.53 |
